Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03061305. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Many patients are treated for advanced cancer without knowledge of underlying molecular features that might indicate FDA approved therapies or potential eligibility for biomarker-selected clinical trials. The Strata Trial (STR-001-001) has been initiated by Strata Oncology to evaluate the clinical benefit of systematic comprehensive genomic profiling for participants with advanced cancer using real-world data and endpoints, while assessing the proportion of participants available for clinical trials and approved targeted therapies in advanced and/or aggressive cancers. The Strata Trial uses surplus, or leftover, tumor specimens for molecular profiling and does not require additional study-specific procedures.
Study identification
- NCT ID
- NCT03061305
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 58,213 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2016 (Actual)
- Primary completion
- Jun 27, 2024 (Actual)
- Completion
- Jun 27, 2024 (Actual)
- Last update posted
- Jan 31, 2025
2016 – 2024
United States locations
- U.S. sites
- 40
- U.S. states
- 19
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama, Birmingham | Birmingham | Alabama | 35294 | — |
| Kaiser Permanente - Southern California | Pasadena | California | 91101 | — |
| Kaiser Permanente - Northern California | Vallejo | California | 94589 | — |
| SCL Health | Broomfield | Colorado | 80021 | — |
| Kaiser Permanente Colorado | Denver | Colorado | 80218 | — |
| Christiana Care Health System | Newark | Delaware | 19713 | — |
| SwedishAmerican | Rockford | Illinois | 61114 | — |
| Baptist Health | Lexington | Kentucky | 40503 | — |
| Christus Health | Lake Charles | Louisiana | 70605 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| Kaiser Permanente - Mid-Atlantic | Rockville | Maryland | 20852 | — |
| Minnesota Oncology - Burnsville | Burnsville | Minnesota | 55337 | — |
| Minnesota Oncology - Coon Rapids | Coon Rapids | Minnesota | 55433 | — |
| Fairview Southdale Hospital | Edina | Minnesota | 55435 | — |
| Minnesota Oncology - Maplewood Cancer Center | Maplewood | Minnesota | 55109 | — |
| St. John's Hospital | Maplewood | Minnesota | 55109 | — |
| Metro-Minnesota Community Oncology Research Consortium | Minneapolis | Minnesota | 55101 | — |
| Regions Hospital | Minneapolis | Minnesota | 55101 | — |
| Minnesota Oncology - Minneapolis | Minneapolis | Minnesota | 55404 | — |
| North Memorial Health Care | Robbinsdale | Minnesota | 55422 | — |
| Park Nicollet Health Services | Saint Louis Park | Minnesota | 55416 | — |
| Minnesota Oncology - Edina | Saint Louis Park | Minnesota | 55435 | — |
| Minnesota Oncology - Woodbury Clinic | Woodbury | Minnesota | 55125 | — |
| North Mississippi Medical Center | Tupelo | Mississippi | 38801 | — |
| University of North Carolina, Chapel Hill | Chapel Hill | North Carolina | 27514 | — |
| Hayworth Cancer Center | High Point | North Carolina | 27262 | — |
| UNC REX Healthcare | Raleigh | North Carolina | 27607 | — |
| Kettering Health Network | Kettering | Ohio | 45429 | — |
| Kaiser Permanente Northwest | Portland | Oregon | 97227 | — |
| Lehigh Valley Health Network | Allentown | Pennsylvania | 18103 | — |
| Prisma Health Cancer Institute | Greenville | South Carolina | 29605 | — |
| Bon Secours St. Francis | Greenville | South Carolina | 29607 | — |
| UTHealth - Memorial Hemann Cancer Institute | Houston | Texas | 77030 | — |
| Bon Secours Midlothian | Midlothian | Virginia | 23114 | — |
| MultiCare | Tacoma | Washington | 98405 | — |
| Gundersen Health System | La Crosse | Wisconsin | 54601 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
| Marshfield Clinic | Marshfield | Wisconsin | 54449 | — |
| Aurora Research Institute | Milwaukee | Wisconsin | 53226 | — |
| ProHealth Care | Waukesha | Wisconsin | 53188 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03061305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 31, 2025 · Synced Nov 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.